Pfizer (NYSE:PFE) Price Target and Stock Analysis

Core Viewpoint - UBS has set a price target of $25 for Pfizer, indicating a slight overvaluation based on the current stock price of $25.43, which reflects a minor difference of -1.69% from the target [1][6]. Company Performance - Pfizer's stock has declined by 2.3% over the past month, underperforming compared to the Zacks S&P 500 composite, which increased by 0.6%, and the Zacks Large Cap Pharmaceuticals industry, which rose by 2.8% [2][6]. - The current stock price of Pfizer is $25.43, showing a slight increase of 1.05% or $0.265 from the previous day, with fluctuations between $25.18 and $26 [3]. - Over the past year, Pfizer's stock has experienced significant volatility, reaching a high of $27.69 and a low of $20.92 [3]. Market Capitalization and Trading Activity - Pfizer's market capitalization is approximately $144.59 billion, indicating its substantial size within the pharmaceutical industry [4][6]. - The trading volume for Pfizer on the New York Stock Exchange is 38,061,592 shares, reflecting active investor interest [4][6]. Earnings Projections - Evaluating changes in Pfizer's future earnings projections is crucial for understanding its present value and making informed investment decisions [5].